UNSPSC 51431605: Gallopamil

This classification denotes a calcium channel blocker with the molecular formula C28H40N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 39WPC8JHR8, chemically known as 5-((3,4-dimethoxyphenethyl)methylamino)-2-isopropyl-2-(3,4,5-trimethoxyphenyl)valeronitrile but generally known as gallopamil, which bears US NIH Compound Identifier 1234. European Medicines Agency schedules Gallopamil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07874MIG.

UNSPSC 51431605 Gallopamil is a Commodity code covering specific pharmaceutical formulations supplied to state and local emergency medical services, healthcare agencies, and multi-state cooperative purchasing consortiums. State and local governments procure gallopamil and related medications as part of advanced life support drug inventories for fire departments, emergency response units, and pharmacy benefit programs. The code captures both direct procurement of individual medication units and participation in multi-state pharmaceutical supply frameworks that aggregate demand across participating jurisdictions.

Issuing bodies soliciting under this code include municipal fire and rescue departments (city purchasing offices), state health agencies, and multi-state cooperative purchasing alliances. The City of Tampa's Purchasing Department and the Minnesota Department of Administration represent distinct procurement models—direct municipal procurement for operational emergency supplies and cooperative vehicle procurement serving multiple state and local members. The Texas Health and Human Services Commission's exploratory RFI signals emerging state-level interest in alternative pharmaceutical distribution models outside traditional pharmacy benefit manager channels. Recent activity clusters in Florida, Minnesota (with Oregon participation through MMCAP), and Texas. Representative opportunities include the City of Tampa's sealed bid for Advanced Life Support Medications (Bid No. 26-P-00188, due April 8, 2026, estimated contract value $40,000) supplying labetalol, epinephrine, adenosine, and diltiazem for Tampa Fire Rescue; the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products (due March 26, 2026), requiring NDC-level specifications and wholesaler distribution through AmerisourceBergen, Cardinal Health, and Morris & Dickson; and the Texas HHS Commission's RFI on direct-to-manufacturer prescription fulfillment (response deadline April 3, 2026), exploring vendor capacity for alternative contracting models outside PBM and GPO intermediaries.